Why we can't trust clinical guidelines
BMJPublished 14 June 2013
Jeanne Lenzer
Citations146
SJR quartileQ1
SJR score2.98
SNIP9.45
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Despite repeated calls to prohibit or limit conflicts of interests among authors and sponsors of clinical guidelines, the problem persists and Jeanne Lenzer investigates.
Abstract
Despite repeated calls to prohibit or limit conflicts of interests among authors and sponsors of clinical guidelines, the problem persists. Jeanne Lenzer investigates
Keywords
MedicineEconomics, Econometrics and Finance
New England Journal of MedicineTissue Plasminogen Activator for Acute Ischemic Stroke
11,541 Citations1995The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
StrokeGuidelines for the Early Management of Patients With Acute Ischemic Stroke
7,657 Citations2013Edward C. Jauch, Jeffrey L. Saver +13 more
These guidelines supersede the prior 2007 guidelines and 2009 updates and support the overarching concept of stroke systems of care and detail aspects of stroke care from patient recognition; emergency medical services activation, transport, and triage; through the initial hours in the emergency department and stroke unit.
National Academies Press eBooksClinical Practice Guidelines We Can Trust
3,070 Citations2011Board on Health Care Services
Clinical Practice Guidelines The authors Can Trust shows how clinical practice guidelines can enhance clinician and patient decision-making by translating complex scientific research findings into recommendations for clinical practice that are relevant to the individual patient encounter, instead of implementing a one size fits all approach to patient care.
New England Journal of MedicineCorrection of Anemia with Epoetin Alfa in Chronic Kidney Disease
2,752 Citations2006Ajay Singh, Lynda A. Szczech +5 more
The use of a target hemoglobin level of 13.5 g per deciliter (as compared with 11.3 g perDeciliter) was associated with increased risk and no incremental improvement in the quality of life and the use of epoetin alfa targeted to achieve a level of 11.4 g perdeciliter was not associated with an increased risk.
Cochrane Database of Systematic ReviewsThrombolysis for acute ischaemic stroke
1,354 Citations2014Joanna M. Wardlaw, Veronica Murray +2 more
Thrombolytic therapy, mostly administered up to six hours after ischaemic stroke, significantly reduced the proportion of participants who were dead or dependent at three to six months after stroke and increased the risk of symptomatic intracranial haemorrhage.
New England Journal of MedicineA Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury
830 Citations1990
Studies in animals indicate that methylprednisolone and naloxone are both potentially beneficial in acute spinal-cord injury, but whether any treatment is clinically effective remains uncertain.
Health AffairsThe Promises And Pitfalls Of Evidence-Based Medicine
462 Citations2005Stefan Timmermans, Aaron Mauck
Evidence-based medicine aims to address the persistent problem of clinical practice variation with the help of various tools, including standardized practice guidelines, but studies show that few guidelines lead to consistent changes in provider behavior.
Cochrane Database of Systematic ReviewsSteroids for acute spinal cord injury
444 Citations2012Michael B. Bracken
High-dose methylprednisolone steroid therapy is the only pharmacologic therapy shown to have efficacy in a phase three randomized trial when administered within eight hours of injury and has been shown to improve neurologic outcome up to one year post-injury.
NeurosurgeryPharmacological Therapy for Acute Spinal Cord Injury
432 Citations2013R. John Hurlbert, Mark N. Hadley +7 more
Clinicians considering MP therapy should bear in mind that the drug is not Food and Drug Administration approved for this application, and there is no Class I or Class II medical evidence supporting the clinical benefit of MP in the treatment of acute SCI.
Annals of Internal MedicineThe Vexing Problem of Guidelines and Conflict of Interest: A Potential Solution
318 Citations2010Gordon Guyatt, Elie A. Akl +8 more
Tension remains between the competing goals of optimizing guideline quality by using the experience and insight of experts and ensuring that financial and intellectual conflicts of interest do not influence recommendations, so a strategy comprising 3 innovative aspects to address this tension is developed.
Journal of Spinal DisordersA Critical Appraisal of the Reporting of the National Acute Spinal Cord Injury Studies (II and III) of Methylprednisolone in Acute Spinal Cord Injury
293 Citations2000William P. Coleman, Edward Benzel +13 more
The NASCIS group's decision to admit persons with minor SCIs with minimal or no motor deficit not only enables statistical artifacts it complicates the interpretation of results from the population actually sampled, and the results of these studies show statistical artifacts that call their results into question.
Archives of Internal MedicineFailure of Clinical Practice Guidelines to Meet Institute of Medicine Standards
285 Citations2012Justin W. Kung, Ram R. Miller +1 more
Analysis of a random sample of clinical practice guidelines archived on the NGC website as of June 2011 demonstrated poor compliance with IOM standards, with little if any improvement over the past 2 decades.
Steroids and Spinal Cord Injury
256 Citations1998Shanker Nesathurai
Both NASCIS 2 and 3 trials are often cited as evidence that high-dose methylprednisolone is an efficacious intervention in the management of acute spinal cord injury, but neither of these studies convincingly demonstrate the benefit of steroids.
Annals of Emergency MedicineSurvey of Emergency Physicians About Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke
170 Citations2005Devin L. Brown, William G. Barsan +3 more
Symptomatic intracerebral hemorrhage risk is the factor most likely to preclude rt-PA use by emergency physicians, and treatment trials that aim to reduce symptomatic intrusion hemorrhages risk to 2% to 3% are likely to stimulate the interest of emergency physicians in the use of thrombolytics.
JAMAHow to Decide Whether a Clinical Practice Guideline Is Trustworthy
154 Citations2013David F. Ransohoff, Michael Pignone +1 more
In a recent evaluation of 114 randomly chosen guidelines, researchers found poor adherence to the IOM standards, raising questions about the best approach to use guidelines as a benchmark of excellent care.
BMJAlteplase for stroke: money and optimistic claims buttress the “brain attack” campaignCommentary: Who pays the guideline writers?Commentary: Thrombolysis in stroke: it works!
110 Citations2002Jeanne Lenzer, Charles Warlow +3 more
The example of guidelines produced by the American Heart Association are examined, in which a treatment recommendation that could cost more lives than the disease itself was supported by statistics from only one randomised controlled study.
Health AffairsEvidence-Based Guidelines As a Foundation For Performance Incentives
81 Citations2005Alan M. Garber
The problems in implementing evidence-based guidelines are discussed and steps that could be taken to make them more useful as a basis for performance measurement are discussed.
Annals of Emergency MedicineA Graphic Reanalysis of the NINDS Trial
60 Citations2009Jerome R. Hoffman, David L. Schriger
A graphical method of presenting the NINDS trial results provides more detail than was conveyed in the original report and empowers readers to reach their own conclusions about the trial's meaning.
StrokeAttitudes and Beliefs of Michigan Emergency Physicians Toward Tissue Plasminogen Activator Use in Stroke
39 Citations2010Phillip Scott, Zhenzhen Xu +7 more
In this cohort, emergency physician attitudes and beliefs toward intravenous tPA use in stroke are considerably more favorable than previously reported.
Emergency Medicine AustralasiaHow is more negative evidence being used to support claims of benefit: The curious case of the third international stroke trial (<scp>IST</scp>‐3)
19 Citations2012Jerome R. Hoffman, Richelle J. Cooper
The third international stroke trial is the latest addition to the long-running controversy over the use of thrombolysis in AIS, but the claims being made about ‘benefit’ in this trial seem to go beyond the common situation where well meaning people can look at the same information and come to wildly disparate conclusions.
InjuryFailure to administer methylprednisolone for acute traumatic spinal cord injury—a prospective audit of 100 patients from a regional spinal injuries unit
16 Citations2002Sean Molloy, F Middleton +1 more
Evidence based medicine is not being practiced in the management of patients with acute spinal cord injury as only 25% of the patients admitted to the spinal injuries unit received methylprednisolone at the referring hospital according to the NASCIS protocols.
Emergency Medicine AustralasiaBelieving is seeing: Stroke thrombolysis remains unproven after the third international stroke trial (<scp>IST</scp>‐3)
12 Citations2012Daniel M Fatovich
A recent graphic reanalysis of the original NINDS data suggests that imbalance in baseline stroke severity was likely responsible for most, if not all, the difference in outcome between treatment groups, and all purported benefits of tPA disappear.
BMJConflicts of interest in guideline panel members
12 Citations2011E.A.M. Gale
A change in the culture of medicine is needed; legislation is not enough to change the face of medicine in Africa.
The LancetThrombolysis in acute ischaemic stroke
6 Citations2012Daniel M Fatovich, Stephen Macdonald +1 more
This monograph presents a meta-analysis of thrombolysis with alteplase 3 to 4·5 hours after acute ischemic stroke with findings that support the use of rt-PA for ischaemic stroke.
Emergency Medicine JournalRole of mean platelet volume in the diagnosis of acute coronary events
2 Citations2011Meltem Refıker Ege, Savaş Açıkgöz +1 more
In this report, similar to the findings of Yilmaz et al ,2 the authors have shown that MPV was an early and independent predictor of acute coronary syndrome in patients with severe coronary syndrome.
Emergency Medicine JournalResponse to the recent best evidence topic on the use of thrombolysis in stroke
1 Citations2011Daniel M Fatovich
The letters by Kaye and Ferguson highlight some issues in the controversy on thrombolytics, but it is important to look at the totality of the evidence in more detail.